Autor/in Otremba, B Bauerfeind, I 1 Camara, O 1 Gluz, O 1 Hasmueller, S 1 Janni, W 1 Lorenz-Schlüter, C 1 Mahner, Sven 1 Oskay-Ozcelik, G 1 Schem, C 1 Schindlbeck, C 1 Schmalfeldt, B 1 Schmidt, M 1 Sehouli, Jalid 1 Seipelt, G 1 Sotlar, K 1 Tesch, H 1 Witzel, I 1 Wuerstlein, R 1 von Schumann, R 1 alle zeigenListe einklappen
The West German Study Group Breast Cancer Intrinsic Subtype study: a prospective multicenter decision impact study utilizing the Prosigna assay for adjuvant treatment decision-making in estrogen-receptor-positive, HER2-negative early-stage breast cancer Wuerstlein, R Sotlar, K Gluz, O Otremba, B von Schumann, R Witzel, I Schindlbeck, C 2016 - Forschungsinformationssystem des UKE
Pegylated liposomal doxorubicin (CAELYX) in patients with advanced ovarian cancer: results of a German multicenter observational study. Sehouli, Jalid Camara, O Schmidt, M Mahner, Sven Seipelt, G Otremba, B Schmalfeldt, B 2009 - Forschungsinformationssystem des UKE
